NasdaqGS - Nasdaq Real Time Price USD

Atea Pharmaceuticals, Inc. (AVIR)

Compare
3.2700
-0.0700
(-2.10%)
At close: January 10 at 4:00:01 PM EST
3.2700
0.00
(0.00%)
After hours: January 10 at 4:01:36 PM EST

Research Analysis

Earnings Per Share

Consensus EPS
 

Revenue vs. Earnings

Revenue --
Earnings -31.15M
Q4'23
Q1'24
Q2'24
Q3'24
-60M
-40M
-20M
0
 

Analyst Recommendations

  • Strong Buy
  • Buy
  • Hold
  • Underperform
  • Sell
 

Analyst Price Targets

6.20
7.40 Average
3.2700 Current
8.00 High

Earnings Estimate

Currency in USD Current Qtr. (Dec 2024)Next Qtr. (Mar 2025)Current Year (2024)Next Year (2025)
No. of Analysts 3233
Avg. Estimate -0.29-0.37-1.81-1.58
Low Estimate -0.38-0.41-1.98-1.68
High Estimate -0.13-0.33-1.5-1.42
Year Ago EPS -0.47-0.75-1.63-1.81

Revenue Estimate

Currency in USD Current Qtr. (Dec 2024)Next Qtr. (Mar 2025)Current Year (2024)Next Year (2025)
No. of Analysts 2122
Avg. Estimate --------
Low Estimate --------
High Estimate --------
Year Ago Sales --------
Sales Growth (year/est) 0.00%0.00%0.00%0.00%

Earnings History

Currency in USD 12/31/2023 3/31/2024 6/30/2024 9/30/2024
EPS Est. -0.5-0.61-0.77-0.43
EPS Actual -0.47-0.75-0.48-0.37
Difference 0.03-0.140.290.06
Surprise % 5.37%-23.81%37.35%13.02%

EPS Trend

Currency in USD Current Qtr. (Dec 2024)Next Qtr. (Mar 2025)Current Year (2024)Next Year (2025)
Current Estimate -0.29-0.37-1.81-1.58
7 Days Ago -0.29-0.37-1.81-1.58
30 Days Ago -0.44-0.45-2.21-1.79
60 Days Ago -0.44-0.45-2.21-1.79
90 Days Ago -0.58-0.66-2.54-2.31

EPS Revisions

Currency in USD Current Qtr. (Dec 2024)Next Qtr. (Mar 2025)Current Year (2024)Next Year (2025)
Up Last 7 Days 1112
Up Last 30 Days 1112
Down Last 7 Days --------
Down Last 30 Days --------

Growth Estimates

Current Qtr.Next Qtr.Current YearNext Year
AVIR 38.38%50.67%-10.74%12.41%
S&P 500 8.66%11.51%14.05%13.39%

Upgrades & Downgrades

Upgrade Morgan Stanley: Underweight to Equal-Weight 8/13/2024
Downgrade JP Morgan: Neutral to Underweight 8/10/2023
Maintains JP Morgan: Neutral 3/16/2023
Maintains SVB Leerink: Market Perform 1/27/2023
Maintains Morgan Stanley: Underweight 1/24/2023
Maintains Morgan Stanley: Underweight 8/15/2022

Related Tickers